BDI MONTHLY UPDATES
What's New in April 2025
Episode 13 in BDI’s new video series, “Empathy in Diabetes Care: Does It Really Make a Difference?”
After an unexpected hiatus, BDI Briefs— our video program that examines important aspects of the emotional side of diabetes– is back and resuming its monthly schedule! In this month’s episode of BDI Briefs, we discuss a recently published study that highlights how social support can lead to significant glycemic benefits. Bottom line: when you have someone in your life who is rooting for you, it can make all the difference in the world. Join Dr. Guzman (BDI Director of Clinical Education), Dr. Polonsky (BDI President), and Scott Johnson (famed diabetes blogger and a dear BDI friend) for this stimulating discussion.
BDI's new website is live!
After many years, it was time to refresh our online home, www.behavioraldiabetes.org. We have streamlined the content and made lots of other significant changes. More updates and changes will be occurring over the next few months so, please come back and visit us. We hope you will find the website easier to navigate and even more useful than before!
NEW Scientific Publication
Dr. Fisher (BDI Research Director) served as a co-author on an important new publication about addressing the problem of diabetes distress in the primary care setting: Addressing Diabetes Distress in Primary Care: Where Are We Now, and Where Do We Need to Go?
JOIN US FOR A LOCAL EVENT
Monthly Events
BEHAVIORAL DIABETES INSTITUTE
Recent Publications
During 2024, BDI staff authored or co-authored 24 scientific publications (which includes the 3 new ones highlighted above) and 8 published abstracts at major scientific meetings. You can see the full list right HERE. Our work has covered a wide range, including studies on diabetes distress, the value of continuous glucose monitoring (CGM) for people with diabetes, the impact of diabetes medications on quality of life, the benefits of diabetes technology for people with type 1 and type 2 diabetes, diabetes stigma, and more.
Treatment satisfaction and time in range after 16 weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes
Authors: Viral N Shah, Terry Dex, Luigi Meneghini, Amélie Rodrigues, William H Polonsky Abstract Aims: In Soli-CGM, treatment with iGlarLixi (insulin
Addressing Diabetes Distress in Primary Care: Where Are We Now, and Where Do We Need to Go?
Authors: Marisa Kostiuk, E Seth Kramer, Andrea Nederveld, Danielle M Hessler, Lawrence Fisher, Jessica A Parascando, Tamara K Oser Abstract